SREBF2

UniProt ID: Q12772
Organism: Homo sapiens
Review Status: DRAFT
πŸ“ Provide Detailed Feedback

Gene Description

SREBF2 encodes sterol regulatory element-binding protein 2 (SREBP-2), a 1141-residue basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factor made as an inactive precursor inserted in the endoplasmic reticulum membrane as a hairpin of two transmembrane segments. Its C-terminal regulatory domain binds the sterol sensor SCAP. When sterols are abundant, SCAP binds INSIG proteins and the SCAP-SREBP-2 complex is held in the ER. When cellular cholesterol falls, SCAP escorts SREBP-2 in COPII vesicles to the Golgi, where site-1 protease (MBTPS1) cuts the luminal loop and site-2 protease (MBTPS2) cuts within the first transmembrane segment. This releases the N-terminal bHLH-Zip domain, which dimerizes, is imported into the nucleus by importin-beta, and binds sterol regulatory elements (SRE-1). It also binds E-box sequences. With coactivators such as CBP/p300 and the Mediator subunit MED15, nuclear SREBP-2 activates transcription of the genes for cholesterol biosynthesis (HMGCS1, HMGCR and later pathway enzymes) and uptake (LDLR), and of feedback regulators such as INSIG1 and PCSK9. This makes it the main transcriptional controller of cellular cholesterol homeostasis. The nuclear form is rapidly ubiquitinated and degraded by the proteasome. In some contexts, such as ABCA1 in endothelial cells, nuclear SREBP-2 represses transcription.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000122 negative regulation of transcription by RNA polymerase II
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: Nuclear SREBP2 represses ABCA1 transcription in endothelial cells.
Reason: Direct E-box-dependent repression of ABCA1 is shown. It is context-specific (endothelial cells) and secondary to the activator role.
Supporting Evidence:
PMID:15358760
Overexpression of the N terminus of SREBP2 (SREBP2(N)), an active form of SREBP2, also inhibited the ABCA1 promoter activity.
PMID:15358760
The conserved E-box motif was responsible for the SREBP2(N)-mediated inhibition
GO:0000122 negative regulation of transcription by RNA polymerase II
IMP
PMID:19098903
SRF and myocardin regulate LRP-mediated amyloid-beta clearan...
KEEP AS NON CORE
Summary: SREBP2 knockdown relieves LRP1 repression in vascular smooth muscle cells.
Reason: Knockdown evidence that SREBP2 is required for LRP1 downregulation downstream of MYOCD/SRF. Non-core.
Supporting Evidence:
PMID:19098903
silencing SREBP2 with siSREBP2 resulted in loss of LRP suppression after Ad.MYOCD gene transfer
GO:0000139 Golgi membrane
EXP
PMID:26311497
PAQR3 modulates cholesterol homeostasis by anchoring Scap/SR...
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
PMID:26311497
when SREBP-2 was co-expressed with PAQR3, the majority of SREBP-2 was localized in the GA together with PAQR3
GO:0000139 Golgi membrane
EXP
PMID:28849786
SREBP-regulated lipid metabolism: convergent physiology - di...
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Golgi apparatus membrane {ECO:0000269|PubMed:26311497, ECO:0000269|PubMed:28849786}
GO:0000139 Golgi membrane
IEA
GO_REF:0000044
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Golgi apparatus membrane {ECO:0000269|PubMed:26311497, ECO:0000269|PubMed:28849786}
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-1655842
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
Reactome:R-HSA-1655842
S1P (MBTPS1, SKI-1), a membrane-bound protease in the Golgi, cleaves the intralumenal loop of SREBP1A/1C/2 (SREBF1A/1C/2)
GO:0000139 Golgi membrane
TAS
Reactome:R-HSA-1655851
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
Reactome:R-HSA-1655851
S2P(MBTPS2), a membrane-bound protease in the Golgi, cleaves within the transmembrane region of SREBP1A/1C/2 (SREBF1A/1C/2)
GO:0000139 Golgi membrane
TAS
Reactome:R-NUL-1655840
ACCEPT
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: The Golgi membrane is where the precursor is proteolytically activated, a defining step of SREBF2 regulation.
Supporting Evidence:
PMID:11994399
SREBPs lose their access to S1P and S2P in the Golgi apparatus, so their bHLH-Zip domains cannot be released from the ER membrane
GO:0000247 C-8 sterol isomerase activity
IDA NOT
PMID:12941800
Identification and pharmacological characterization of SRBP-...
REMOVE
Summary: NOT C-8 sterol isomerase activity, from a paper on SRBP-2, an SR31747A-binding EBP-like protein.
Reason: The abstract states the protein studied is a 206-residue SR31747A-binding protein homologous to the sterol isomerase HSI (EBP), named SRBP-2. It is not SREBP-2 (1141 aa), so the row is a name-collision mis-attribution stated explicitly in the abstract. SREBF2 has no isomerase domain, and the negative assertion carries no information about it.
Supporting Evidence:
PMID:12941800
The 1142-bp cDNA was found to encode a 206 amino acid protein not related to SRBP-1.
PMID:12941800
In contrast with HSI, the protein also did not exhibit detectable isomerase activity.
GO:0000785 chromatin
ISA
GO_REF:0000113
KEEP AS NON CORE
Summary: TFClass-based chromatin localization for a sequence-specific TF.
Reason: SREBF2 associates with promoter chromatin (ChIP at ABCA1). True, but a generic consequence of being a DNA-binding TF.
Supporting Evidence:
PMID:15358760
Chromatin immunoprecipitation assay demonstrated that serum starvation enhanced the association of SREBP2 and the ABCA1 promoter in ECs.
GO:0000976 transcription cis-regulatory region binding
IEA
GO_REF:0000107
MODIFY
Summary: Transcription cis-regulatory region binding from mouse ortholog transfer.
Reason: Correct but general. The sequence-specific pol II cis-regulatory region term GO:0000978 is supported and already carried by the gene.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IBA
GO_REF:0000033
ACCEPT
Summary: SREBF2 binds SRE-1 and E-box sequences in RNA polymerase II promoters.
Reason: Core DNA-binding activity of the nuclear form. Inherited from the SREBP clade node PTN002488844, which SREBF2 is clearly inside. Same verdict as the SREBF1 IBA row from the same node.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
file:human/SREBF2/SREBF2-uniprot.txt
Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (PubMed:12177166, PubMed:7903453).
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
ACCEPT
Summary: SREBF2 binds SRE-1 and E-box sequences in RNA polymerase II promoters.
Reason: EMSA and ChIP show nuclear SREBP2 binding to the ABCA1 promoter E-box and associating with the ABCA1 promoter in endothelial cells. This is pol II cis-regulatory sequence-specific binding.
Supporting Evidence:
PMID:15358760
sterol depletion and SREBP2(N) overexpression induced the binding of SREBP2(N) to both consensus and ABCA1-specific E-box
PMID:15358760
Chromatin immunoprecipitation assay demonstrated that serum starvation enhanced the association of SREBP2 and the ABCA1 promoter in ECs.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IBA
GO_REF:0000033
ACCEPT
Summary: SREBF2 is a bHLH-Zip transcription factor; its released N-terminal domain binds SRE-1 in RNA polymerase II promoters and activates cholesterol synthesis and uptake genes.
Reason: Core activity. The PAINT node PTN002488844 covers the SREBP clade (human SREBF1/SREBF2, mouse and rat orthologs, fly HLH106, worm sbp-1), and SREBF2 sits well inside it; its own experimental annotations are among the descendant evidence. Same verdict as the matching SREBF1 IBA row, which descends from the same node. GO:0000981 is the level the human SREBP GO-CAM (gocams/6205c24300000880) uses, and it covers both the main activator role and the context-specific repression reported for ABCA1.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IDA
PMID:12177166
Transcriptional activities of nuclear SREBP-1a, -1c, and -2 ...
ACCEPT
Summary: SREBF2 is a bHLH-Zip transcription factor; its released N-terminal domain binds SRE-1 in RNA polymerase II promoters and activates cholesterol synthesis and uptake genes.
Reason: Reporter assays in HepG2 cells show nuclear SREBP-2 strongly activates promoters carrying classic SREs (HMG-CoA synthase, HMG-CoA reductase, LDLR class). Direct support for RNA polymerase II-specific DNA-binding transcription factor activity.
Supporting Evidence:
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
PMID:12177166
SREBP-2 was inactive in spite of its ability to bind to the E-box
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IDA
PMID:38503280
A gut-derived hormone regulates cholesterol metabolism.
ACCEPT
Summary: SREBF2 is a bHLH-Zip transcription factor; its released N-terminal domain binds SRE-1 in RNA polymerase II promoters and activates cholesterol synthesis and uptake genes.
Reason: The Cholesin-GPR146 paper uses SREBP2-dependent transcription of cholesterol synthesis genes as its readout. The abstract only states SREBP2-controlled cholesterol synthesis, but the activity is well established, so the curator's full-text IDA is accepted.
Supporting Evidence:
PMID:38503280
inhibiting PKA signaling and thereby suppressing SREBP2-controlled cholesterol synthesis in the liver
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IMP
PMID:32497488
Mutations in SREBF1, Encoding Sterol Regulatory Element Bind...
ACCEPT
Summary: SREBF2 is a bHLH-Zip transcription factor; its released N-terminal domain binds SRE-1 in RNA polymerase II promoters and activates cholesterol synthesis and uptake genes.
Reason: The cached abstract of this SREBF1 IFAP-syndrome paper does not describe SREBF2 assays, but the full text, which the curator read, may include an SREBF2 comparison. The activity is clearly correct for SREBF2, so I defer to the curator rather than second-guess it from the abstract.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
ISA
GO_REF:0000113
ACCEPT
Summary: SREBF2 is a bHLH-Zip transcription factor; its released N-terminal domain binds SRE-1 in RNA polymerase II promoters and activates cholesterol synthesis and uptake genes.
Reason: TFClass places SREBF2 in the bHLH-ZIP SREBP family (1.2.6). This agrees with the experimental evidence.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: Nuclear SREBP2 represses the ABCA1 promoter through an E-box in endothelial cells.
Reason: Promoter mutation and binding data support direct E-box-dependent repression of ABCA1 by nuclear SREBP2. This is a real but context-specific activity, peripheral to the core activator role.
Supporting Evidence:
PMID:15358760
Overexpression of the N terminus of SREBP2 (SREBP2(N)), an active form of SREBP2, also inhibited the ABCA1 promoter activity.
PMID:15358760
The conserved E-box motif was responsible for the SREBP2(N)-mediated inhibition
PMID:15358760
sterol depletion and SREBP2(N) overexpression induced the binding of SREBP2(N) to both consensus and ABCA1-specific E-box
GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
IMP
PMID:19098903
SRF and myocardin regulate LRP-mediated amyloid-beta clearan...
KEEP AS NON CORE
Summary: SREBP2 knockdown abolishes MYOCD/SRF-driven LRP1 suppression in vascular smooth muscle cells.
Reason: The knockdown shows SREBP2 is needed for LRP1 downregulation. The paper relies on earlier work for direct repression, so this row is weaker than the ABCA1 IDA. It is kept consistent with the other rows for this term as a non-core, context-specific repressor activity.
Supporting Evidence:
PMID:19098903
silencing SREBP2 with siSREBP2 resulted in loss of LRP suppression after Ad.MYOCD gene transfer
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
IEA
GO_REF:0000107
ACCEPT
Summary: Ensembl Compara transfer from mouse Srebf2 of DNA-binding transcription activator activity, RNA polymerase II-specific.
Reason: SREBF2 is primarily a transcriptional activator of SRE-containing pol II promoters (HMGCS1, HMGCR, LDLR, INSIG1). This is the most precise MF term for the core activity.
Supporting Evidence:
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
PMID:11994399
SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
GO:0003677 DNA binding
IEA
GO_REF:0000107
MODIFY
Summary: Generic DNA binding from mouse ortholog transfer.
Reason: Correct but general. SREBF2 binds specific sequences (SRE-1, E-box) in pol II cis-regulatory regions, so GO:0000978 (already annotated by IBA and IDA) is the right term.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
file:human/SREBF2/SREBF2-uniprot.txt
Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (PubMed:12177166, PubMed:7903453).
GO:0003700 DNA-binding transcription factor activity
IEA
GO_REF:0000107
MODIFY
Summary: Ensembl Compara transfer of the generic DNA-binding transcription factor activity term.
Reason: Correct but general. The RNA polymerase II-specific activator term GO:0001228, which the gene already carries, is supported by reporter-assay evidence (PMID:12177166).
Supporting Evidence:
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
GO:0005515 protein binding
IPI
PMID:10976766
A set of proteins interacting with transcription factor Sp1 ...
REMOVE
Summary: Yeast two-hybrid screen with the SP1 activation domain retrieved an SREBP-2 fragment.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. The SP1-SREBP-2 contact is a screen hit; no specific molecular function is established by this paper.
GO:0005515 protein binding
IPI
PMID:12855700
Sterol regulatory element-binding protein-2 interacts with h...
MODIFY
Summary: SREBP-2 interacts directly with HNF-4, which potentiates SREBP target-gene expression.
Reason: The paper shows direct binding to the DNA-binding transcription factor HNF-4 and a functional co-operation at SREBP-responsive promoters, so DNA-binding transcription factor binding is a more informative term.
Supporting Evidence:
PMID:12855700
The in vitro pull-down and in vivo co-immunoprecipitation experiments showed the direct interaction between SREBP-2 and HNF-4.
PMID:12855700
These data provide a novel pathway by which HNF-4 potentiates the SREBP functions and stimulates expression of SREBP-responsive genes in enterohepatic cells.
GO:0005515 protein binding
IPI
PMID:16799563
An ARC/Mediator subunit required for SREBP control of choles...
MODIFY
Summary: The SREBP activation domain binds the KIX domains of CBP/p300 (CREBBP) and Mediator subunit MED15 (ARC105), recruiting coactivators.
Reason: The interaction is the mechanism by which the SREBP transactivation domain recruits coactivators. Transcription coactivator binding describes it better than bare protein binding.
Supporting Evidence:
PMID:16799563
We previously demonstrated that human SREBPs bind the CREB-binding protein (CBP)/p300 acetyltransferase KIX domain and recruit activator-recruited co-factor (ARC)/Mediator co-activator complexes
PMID:16799563
Here we show that SREBPs use the evolutionarily conserved ARC105 (also called MED15) subunit to activate target genes.
GO:0005515 protein binding
IPI
PMID:16799563
An ARC/Mediator subunit required for SREBP control of choles...
MODIFY
Summary: The SREBP activation domain binds the KIX domains of CBP/p300 (CREBBP) and Mediator subunit MED15 (ARC105), recruiting coactivators.
Reason: The interaction is the mechanism by which the SREBP transactivation domain recruits coactivators. Transcription coactivator binding describes it better than bare protein binding.
Supporting Evidence:
PMID:16799563
We previously demonstrated that human SREBPs bind the CREB-binding protein (CBP)/p300 acetyltransferase KIX domain and recruit activator-recruited co-factor (ARC)/Mediator co-activator complexes
PMID:16799563
Here we show that SREBPs use the evolutionarily conserved ARC105 (also called MED15) subunit to activate target genes.
GO:0005515 protein binding
IPI
PMID:19706601
The sterol-sensing endoplasmic reticulum (ER) membrane prote...
REMOVE
Summary: SREBP-2 binds the ER sterol-sensing E3 ligase TRC8 (RNF139), forming a TRC8-SREBP-2-SCAP complex.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. TRC8 is a regulator acting on SREBP-2, not a partner through which SREBP-2 carries out a function.
Supporting Evidence:
PMID:19706601
TRC8 is capable of binding both SREBP-2 and SREBP cleavage-activated protein (SCAP), thereby forming a TRC8.SREBP-2.SCAP complex.
GO:0005515 protein binding
IPI
PMID:20936779
A human MAP kinase interactome.
REMOVE
Summary: SP1 interaction from a MAP kinase interactome screen.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. High-throughput interaction data.
GO:0005515 protein binding
IPI
PMID:22265415
Mutant p53 disrupts mammary tissue architecture via the meva...
REMOVE
Summary: Mutant p53 associates with SREBP at sterol gene promoters.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. The paper says a direct link between mutant p53 and SREBP proteins is not established.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:34819669
A multi-scale map of cell structure fusing protein images an...
REMOVE
Summary: High-throughput interactome hit (BioPlex, HuRI or multi-scale map), e.g. HLA-DPA1, FHL2 or NFYC.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. Proteome-scale interaction data; no functional consequence for SREBF2 is shown.
GO:0005515 protein binding
IPI
PMID:9242699
Identification of complexes between the COOH-terminal domain...
REMOVE
Summary: Hamster SCAP and SREBP-2 form a complex through their C-terminal domains.
Reason: Generic protein binding is uninformative. Removal does not dispute the reported interaction. The SCAP interaction is the defining feature of SREBF2 and is better captured by the SREBP-SCAP complex terms (GO:0032936, GO:0032937), which are accepted.
Supporting Evidence:
PMID:9242699
Co-immunoprecipitation experiments show that SCAP and SREBP-2 form a complex that can be precipitated with antibodies to either component.
GO:0005634 nucleus
EXP
PMID:11477106
Direct demonstration of rapid degradation of nuclear sterol ...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Nuclear SREBP-2 (aa 1-481) is detected in the nucleus and is rapidly ubiquitinated and degraded by the proteasome there.
Supporting Evidence:
PMID:11477106
The active SREBPs translocate to the nucleus, induce the expression of responsive genes, and are degraded very rapidly.
GO:0005634 nucleus
EXP
PMID:32322062
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for li...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: PCK1-mediated INSIG phosphorylation releases SCAP-SREBP to the Golgi and activates SREBPs, increasing nuclear SREBP.
Supporting Evidence:
PMID:32322062
leading to the translocation of the SCAP-SREBP complex to the Golgi apparatus, the activation of SREBP proteins (SREBP1 or SREBP2)
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Core location of the active transcription factor. Inherited from the SREBP clade node PTN002488844. Same verdict as the SREBF1 IBA row.
Supporting Evidence:
PMID:8674110
The liberated NH2-segment enters the nucleus and activates genes controlling cholesterol synthesis and uptake.
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005634 nucleus
IDA
PMID:12202038
Crucial step in cholesterol homeostasis: sterols promote bin...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Nuclear SREBP fragments are the readout of processing in this study (abstract-only cache).
Supporting Evidence:
PMID:12202038
In sterol-depleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis.
GO:0005634 nucleus
IDA
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Nuclear SREBP-2 is detected by immunoblot as the product of sterol-regulated processing.
Supporting Evidence:
PMID:12242332
When SCAP was overexpressed, we observed the nuclear form of SREBP-2, and it did not decrease when sterols were added
GO:0005634 nucleus
IDA
PMID:12941800
Identification and pharmacological characterization of SRBP-...
ACCEPT
Summary: From a paper on SRBP-2, an EBP-like SR31747A-binding protein, not SREBP-2.
Reason: The cited paper concerns a different 206-aa protein named SRBP-2, so it does not support this row. The claim itself, that SREBF2 localizes to the nucleus, is true from independent evidence (PMID:11477106, PMID:8674110). Because rows are judged on the claim, it is accepted, and the reference problem is recorded in reference_review.
Supporting Evidence:
PMID:12941800
The 1142-bp cDNA was found to encode a 206 amino acid protein not related to SRBP-1.
PMID:11477106
The active SREBPs translocate to the nucleus, induce the expression of responsive genes, and are degraded very rapidly.
GO:0005634 nucleus
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Nuclear SREBP2 binds the ABCA1 promoter (ChIP) in endothelial cells.
Supporting Evidence:
PMID:15358760
Chromatin immunoprecipitation assay demonstrated that serum starvation enhanced the association of SREBP2 and the ABCA1 promoter in ECs.
GO:0005634 nucleus
IDA
PMID:19098903
SRF and myocardin regulate LRP-mediated amyloid-beta clearan...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Immunostaining shows nuclear SREBP2 in vascular smooth muscle cells.
Supporting Evidence:
PMID:19098903
Western blot analysis confirmed that levels of both SREBP2 cytoplasmic long form and short nuclear form were reduced
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Consistent with experimental data.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005634 nucleus
IMP
PMID:32497488
Mutations in SREBF1, Encoding Sterol Regulatory Element Bind...
ACCEPT
Summary: The processed N-terminal SREBF2 fragment enters the nucleus, where it acts as a transcription factor.
Reason: Abstract-only cache for this SREBF1 paper. Nuclear activity of processed SREBF2 is well established, so the curator's annotation is accepted.
Supporting Evidence:
PMID:8674110
The liberated NH2-segment enters the nucleus and activates genes controlling cholesterol synthesis and uptake.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
ACCEPT
Summary: HPA immunofluorescence localizes SREBF2 to the nucleoplasm.
Reason: Consistent with the nuclear transcription factor form.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-1655831
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
Reactome:R-HSA-1655831
The N-terminal domain of SREBP1A,1C,2 (SREBF1A,1C,2) dimerizes and is imported from the cytosol into the nucleus by importin-beta
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2065539
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2065966
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426144
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426146
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426147
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426150
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426151
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426152
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426154
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426155
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426156
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426157
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426161
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426162
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426163
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2426164
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9621400
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9621406
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-9621411
ACCEPT
Summary: Reactome places the nuclear SREBP dimer in the nucleoplasm, where it binds and activates target genes.
Reason: Consistent with the nuclear transcription factor form acting at SRE-containing target genes.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Nucleus {ECO:0000269|PubMed:11477106, ECO:0000269|PubMed:32322062}
GO:0005737 cytoplasm
IDA
PMID:12941800
Identification and pharmacological characterization of SRBP-...
MODIFY
Summary: From a paper on SRBP-2, an EBP-like SR31747A-binding protein, not SREBP-2.
Reason: The cited paper studies a different protein. SREBF2 is in the cytoplasm as an ER/Golgi membrane precursor, so the claim is true but general; refine to ER membrane, consistent with the other cytoplasm rows.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
PMID:12941800
The 1142-bp cDNA was found to encode a 206 amino acid protein not related to SRBP-1.
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005737 cytoplasm
IDA
PMID:19098903
SRF and myocardin regulate LRP-mediated amyloid-beta clearan...
MODIFY
Summary: The SREBP2 precursor is detected in the cytoplasmic fraction ('cytoplasmic long form').
Reason: Correct but general. The cytoplasmic long form is the ER membrane-bound precursor; refine to GO:0005789.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
PMID:19098903
Western blot analysis confirmed that levels of both SREBP2 cytoplasmic long form and short nuclear form were reduced
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005737 cytoplasm
IEA
GO_REF:0000107
MODIFY
Summary: Cytoplasm, transferred from mouse Srebf2.
Reason: Correct but general. Refine to ER membrane, the precursor's location.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005783 endoplasmic reticulum
IDA
GO_REF:0000052
MODIFY
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Correct but general. The precursor is an integral membrane protein, so ER membrane (GO:0005789, already annotated) is the precise term.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005783 endoplasmic reticulum
IDA
PMID:12202038
Crucial step in cholesterol homeostasis: sterols promote bin...
MODIFY
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Correct but general. SREBPs are retained in the ER membrane with SCAP/INSIG; refine to GO:0005789.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
PMID:12202038
facilitates retention of the SCAP/SREBP complex in the ER
GO:0005783 endoplasmic reticulum
IDA
PMID:12941800
Identification and pharmacological characterization of SRBP-...
MODIFY
Summary: From a paper on SRBP-2, an EBP-like SR31747A-binding protein, not SREBP-2.
Reason: The cited paper studies a different 206-aa protein, so it does not support this row. The claim (ER) is nonetheless true of SREBF2 and, like the other ER rows, is refined to ER membrane. The reference problem is recorded in reference_review.
Proposed replacements: endoplasmic reticulum membrane
Supporting Evidence:
PMID:12941800
The 1142-bp cDNA was found to encode a 206 amino acid protein not related to SRBP-1.
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000044
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
GO:0005789 endoplasmic reticulum membrane
NAS
PMID:12202038
Crucial step in cholesterol homeostasis: sterols promote bin...
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
PMID:12202038
facilitates retention of the SCAP/SREBP complex in the ER
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-NUL-1655838
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
PMID:11994399
they are synthesized as inactive precursors bound to the endoplasmic reticulum (ER)
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-NUL-1655840
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
PMID:11994399
they are synthesized as inactive precursors bound to the endoplasmic reticulum (ER)
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-NUL-2317526
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
PMID:11994399
they are synthesized as inactive precursors bound to the endoplasmic reticulum (ER)
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-NUL-2317528
ACCEPT
Summary: The SREBF2 precursor is an ER membrane hairpin protein held in the ER by SCAP-INSIG when sterols are high.
Reason: Core location of the precursor; the ER membrane is where sterol-regulated retention takes place.
Supporting Evidence:
PMID:11994399
they are synthesized as inactive precursors bound to the endoplasmic reticulum (ER)
GO:0005794 Golgi apparatus
NAS
PMID:23564452
Point mutation in luminal loop 7 of Scap protein blocks inte...
MODIFY
Summary: In sterol-depleted cells, SCAP escorts the SREBF2 precursor to the Golgi, where S1P and S2P cleave it in the membrane.
Reason: Correct but general. SREBF2 is a membrane-embedded hairpin protein, so in the Golgi it is in the Golgi membrane (GO:0000139), which the gene already carries.
Proposed replacements: Golgi membrane
Supporting Evidence:
PMID:23564452
Scap is a polytopic protein of the endoplasmic reticulum (ER) that controls cholesterol homeostasis by transporting sterol regulatory element-binding proteins (SREBPs) from the ER to the Golgi complex.
file:human/SREBF2/SREBF2-uniprot.txt
Golgi apparatus membrane {ECO:0000269|PubMed:26311497, ECO:0000269|PubMed:28849786}
GO:0005829 cytosol
TAS
Reactome:R-HSA-1655831
KEEP AS NON CORE
Summary: Reactome places the released N-terminal fragment transiently in the cytosol, between S2P cleavage and importin-beta import.
Reason: Correct as a transit location of the processed fragment. Not where SREBF2 functions.
Supporting Evidence:
Reactome:R-HSA-1655831
The N-terminal domain of SREBP1A,1C,2 (SREBF1A,1C,2) dimerizes and is imported from the cytosol into the nucleus by importin-beta
GO:0005829 cytosol
TAS
Reactome:R-HSA-1655851
KEEP AS NON CORE
Summary: Reactome places the released N-terminal fragment transiently in the cytosol, between S2P cleavage and importin-beta import.
Reason: Correct as a transit location of the processed fragment. Not where SREBF2 functions.
Supporting Evidence:
Reactome:R-HSA-1655851
releasing the N-terminal domain of SREBP1A/1C/2 into the cytosol
GO:0005829 cytosol
TAS
Reactome:R-HSA-2065549
KEEP AS NON CORE
Summary: Reactome places the released N-terminal fragment transiently in the cytosol, between S2P cleavage and importin-beta import.
Reason: Correct as a transit location of the processed fragment. Not where SREBF2 functions.
Supporting Evidence:
Reactome:R-HSA-2065549
The N-terminal domains of SREBPs (SREBP1A/1C/2, SREBFs) dimerize
GO:0005829 cytosol
TAS
Reactome:R-HSA-2065550
KEEP AS NON CORE
Summary: Reactome places the released N-terminal fragment transiently in the cytosol, between S2P cleavage and importin-beta import.
Reason: Correct as a transit location of the processed fragment. Not where SREBF2 functions.
Supporting Evidence:
Reactome:R-HSA-2065550
binds Importin beta-1 via the helix-loop-helix leucine zipper domain of SREBP1A,1C,2
GO:0006357 regulation of transcription by RNA polymerase II
NAS
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
MODIFY
Summary: Regulation of RNA polymerase II transcription.
Reason: Correct but general. SREBF2 positively regulates pol II transcription of its targets, and this paper's data (INSIG1 induction) support GO:0045944, which the gene already carries.
Supporting Evidence:
PMID:12242332
Ponasterone A-mediated induction of nuclear SREBP-1a or SREBP-2 in these cells led to a marked increase in insig-1 mRNA
GO:0006629 lipid metabolic process
TAS
PMID:7903453
SREBP-2, a second basic-helix-loop-helix-leucine zipper prot...
MODIFY
Summary: Lipid metabolic process.
Reason: Very general. SREBP-2 regulates lipid metabolism through transcription, mainly of cholesterol synthesis and uptake genes, so GO:0045542 is the informative replacement.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
PMID:11994399
SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
GO:0008203 cholesterol metabolic process
NAS
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
MODIFY
Summary: Cholesterol metabolic process.
Reason: SREBF2 is a transcription factor and controls cholesterol metabolism rather than catalysing it. The specific regulatory term GO:0045542, already accepted from experimental rows, is the better annotation.
Supporting Evidence:
PMID:11994399
SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
GO:0008593 regulation of Notch signaling pathway
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Transferred from zebrafish srebf2 (A3KNA7), where cholesterol efflux-activated Srebp2 transactivates Notch for HSPC emergence.
Reason: The zebrafish UniProt record says Srebp2 transactivates NOTCH during hematopoietic stem cell emergence (PMID:30705153). This is a developmental, target-gene-specific role and is non-core. Human evidence is lacking.
GO:0009267 cellular response to starvation
IMP
PMID:25339898
Nutrient deprivation induces Ξ±-synuclein aggregation through...
MARK AS OVER ANNOTATED
Summary: Nutrient deprivation activates SREBP2 in a neuronal alpha-synuclein model; SREBP2 knockdown blunts downstream aggregation.
Reason: SREBP2 activation under nutrient deprivation is part of the sterol-depletion response, which is already captured by the SREBP signaling pathway (a child of cellular response to sterol depletion). The knockdown phenotype (alpha-synuclein aggregation) is a downstream disease readout. It does not show SREBF2 executing a starvation response.
Supporting Evidence:
PMID:25339898
nutrient deprivation enhanced Ξ±-syn aggregations concomitant with significant increase of apoptosis as well as ER stress response, SREBP2 activation and cholesterolgenesis
GO:0010886 positive regulation of cholesterol storage
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Nuclear SREBP2 increases cellular cholesterol accumulation.
Reason: Higher cellular cholesterol follows from SREBF2-driven synthesis and uptake (and, in endothelial cells, reduced ABCA1 efflux). PTN002917947 is on the SREBF2 lineage and the term is not wrong, but it describes a downstream outcome, not the core transcriptional role.
Supporting Evidence:
PMID:15358760
Functionally adenovirus-mediated SREBP2(N) expression increased cholesterol accumulation and decreased apoA-I-mediated cholesterol efflux.
GO:0010886 positive regulation of cholesterol storage
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: Nuclear SREBP2 increases cellular cholesterol accumulation.
Reason: Adenoviral SREBP2(N) increases endothelial cholesterol accumulation. Same verdict as the IBA row.
Supporting Evidence:
PMID:15358760
Functionally adenovirus-mediated SREBP2(N) expression increased cholesterol accumulation and decreased apoA-I-mediated cholesterol efflux.
GO:0012507 ER to Golgi transport vesicle membrane
IEA
GO_REF:0000044
ACCEPT
Summary: SCAP-SREBP exits the ER in COPII-coated vesicles.
Reason: The SCAP-SREBF2 complex is packaged into COPII vesicles for ER-to-Golgi transport, which is the regulated step of the pathway.
Supporting Evidence:
PMID:12202038
In sterol-depleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis.
GO:0016020 membrane
IEA
GO_REF:0000107
MODIFY
Summary: Membrane, transferred from mouse Srebf2.
Reason: Correct but general. The precursor is in the ER membrane and, after SCAP-mediated transport, the Golgi membrane; both are already annotated.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:12202038}
file:human/SREBF2/SREBF2-uniprot.txt
Golgi apparatus membrane {ECO:0000269|PubMed:26311497, ECO:0000269|PubMed:28849786}
GO:0032933 SREBP signaling pathway
IDA
PMID:27614840
Sterol regulatory element-binding proteins are regulators of...
ACCEPT
Summary: SREBF2 is the transcription factor effector of the SREBP signaling pathway.
Reason: SREBF2 is the ER-to-nucleus transducer that defines the SREBP signaling pathway. This paper shows that nuclear SREBP-2 binds an SRE in the NIS promoter and activates it; NIS is a non-canonical target, but the pathway role is canonical.
Supporting Evidence:
PMID:27614840
Gel shift assays using oligonucleotides spanning either the wild-type or the mutated SRE at -38 of the NIS 5'-flanking region showed that in vitro-translated nSREBP-1c and nSREBP-2 bind only the wild-type but not the mutated SRE at -38 of NIS.
PMID:8674110
The liberated NH2-segment enters the nucleus and activates genes controlling cholesterol synthesis and uptake.
GO:0032933 SREBP signaling pathway
IEA
GO_REF:0000117
ACCEPT
Summary: ARBA-predicted SREBP signaling pathway.
Reason: Correct. SREBF2 is a defining component of this pathway (PMID:8674110, PMID:12202038).
Supporting Evidence:
PMID:8674110
The liberated NH2-segment enters the nucleus and activates genes controlling cholesterol synthesis and uptake.
PMID:12202038
In sterol-depleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis.
GO:0032933 SREBP signaling pathway
IMP
PMID:27614840
Sterol regulatory element-binding proteins are regulators of...
ACCEPT
Summary: SREBF2 is the transcription factor effector of the SREBP signaling pathway.
Reason: Knocking down SREBP-2 lowers expression of an SRE-containing target gene. This is consistent with the IDA row.
Supporting Evidence:
PMID:27614840
Knockdown of SREBP-1c and SREBP-2 by RNA interference decreased the mRNA and protein concentration of NIS by 30 to 50%
GO:0032936 SREBP-SCAP complex
IEA
GO_REF:0000117
ACCEPT
Summary: In the ER membrane, the SREBF2 precursor forms a complex with SCAP (via the C-terminal domains), and with INSIG when sterols are high.
Reason: Consistent with experimental data (PMID:9242699).
Supporting Evidence:
PMID:9242699
Co-immunoprecipitation experiments show that SCAP and SREBP-2 form a complex that can be precipitated with antibodies to either component.
file:human/SREBF2/SREBF2-uniprot.txt
Forms a tight complex with SCAP, the SCAP-SREBP complex, in the endoplasmic reticulum membrane and the Golgi apparatus (PubMed:19706601, PubMed:26311497, PubMed:32322062).
GO:0032936 SREBP-SCAP complex
IPI
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
ACCEPT
Summary: In the ER membrane, the SREBF2 precursor forms a complex with SCAP (via the C-terminal domains), and with INSIG when sterols are high.
Reason: SCAP-SREBP-2 complex shown by co-immunoprecipitation. The SCAP partnership is essential to SREBF2 regulation.
Supporting Evidence:
PMID:12242332
The coimmunoprecipitation experiment of Fig. 3 B confirms that insig-2 binds to the SCAP/SREBP-2 complex only in the presence of sterols.
PMID:9242699
Co-immunoprecipitation experiments show that SCAP and SREBP-2 form a complex that can be precipitated with antibodies to either component.
GO:0032937 SREBP-SCAP-Insig complex
IDA
PMID:12202038
Crucial step in cholesterol homeostasis: sterols promote bin...
ACCEPT
Summary: In the ER membrane, the SREBF2 precursor forms a complex with SCAP (via the C-terminal domains), and with INSIG when sterols are high.
Reason: Sterols induce SCAP binding to INSIG-1, retaining the SCAP/SREBP complex in the ER.
Supporting Evidence:
PMID:12202038
facilitates retention of the SCAP/SREBP complex in the ER
GO:0032937 SREBP-SCAP-Insig complex
IDA
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
ACCEPT
Summary: In the ER membrane, the SREBF2 precursor forms a complex with SCAP (via the C-terminal domains), and with INSIG when sterols are high.
Reason: INSIG-2 co-immunoprecipitates SCAP and the SREBP-2 precursor in a sterol-dependent manner.
Supporting Evidence:
PMID:12242332
The coimmunoprecipitation experiment of Fig. 3 B confirms that insig-2 binds to the SCAP/SREBP-2 complex only in the presence of sterols.
GO:0032937 SREBP-SCAP-Insig complex
NAS
PMID:12202038
Crucial step in cholesterol homeostasis: sterols promote bin...
ACCEPT
Summary: In the ER membrane, the SREBF2 precursor forms a complex with SCAP (via the C-terminal domains), and with INSIG when sterols are high.
Reason: Same claim as the IDA row from this paper.
Supporting Evidence:
PMID:12202038
facilitates retention of the SCAP/SREBP complex in the ER
GO:0045542 positive regulation of cholesterol biosynthetic process
IDA
PMID:12177166
Transcriptional activities of nuclear SREBP-1a, -1c, and -2 ...
ACCEPT
Summary: SREBF2 activates transcription of cholesterol biosynthetic genes.
Reason: Core process. Nuclear SREBP-2 strongly activates the promoters of cholesterogenic genes (HMG-CoA synthase, HMG-CoA reductase and others), raising cholesterol synthesis. This matches the human SREBP GO-CAM (gocams/6205c24300000880), where GO:0000981 is part_of GO:0045542.
Supporting Evidence:
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
PMID:11994399
SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
GO:0045542 positive regulation of cholesterol biosynthetic process
IDA
PMID:38503280
A gut-derived hormone regulates cholesterol metabolism.
ACCEPT
Summary: SREBF2 activates transcription of cholesterol biosynthetic genes.
Reason: Hepatic SREBP2-controlled cholesterol synthesis is the target of the Cholesin-GPR146-PKA axis.
Supporting Evidence:
PMID:38503280
inhibiting PKA signaling and thereby suppressing SREBP2-controlled cholesterol synthesis in the liver
GO:0045542 positive regulation of cholesterol biosynthetic process
IEA
GO_REF:0000117
ACCEPT
Summary: ARBA-predicted positive regulation of cholesterol biosynthetic process.
Reason: Agrees with the experimental evidence (PMID:12177166, PMID:11994399).
Supporting Evidence:
PMID:11994399
SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
GO:0045542 positive regulation of cholesterol biosynthetic process
IMP
PMID:12177166
Transcriptional activities of nuclear SREBP-1a, -1c, and -2 ...
ACCEPT
Summary: SREBF2 activates transcription of cholesterol biosynthetic genes.
Reason: Mutating the unique bHLH tyrosine abolishes SREBP-2 transactivation of SRE promoters. This is consistent with the IDA row from the same paper.
Supporting Evidence:
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
GO:0045944 positive regulation of transcription by RNA polymerase II
IBA
GO_REF:0000033
ACCEPT
Summary: Positive regulation of RNA polymerase II transcription by SREBF2.
Reason: Activation of SRE-containing pol II promoters is the core mode of action. The IBA node PTN002917947 (vertebrate SREBF2 lineage) is sound, and SREBF2's own experimental data are among its descendant evidence.
Supporting Evidence:
PMID:7903453
In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
PMID:12177166
cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
GO:0045944 positive regulation of transcription by RNA polymerase II
IDA
PMID:12242332
Insig-2, a second endoplasmic reticulum protein that binds S...
ACCEPT
Summary: Positive regulation of RNA polymerase II transcription by SREBF2.
Reason: Induction of nuclear SREBP-2 increases INSIG1 mRNA, which is the sterol feedback loop.
Supporting Evidence:
PMID:12242332
Ponasterone A-mediated induction of nuclear SREBP-1a or SREBP-2 in these cells led to a marked increase in insig-1 mRNA
GO:0045944 positive regulation of transcription by RNA polymerase II
IDA
PMID:12446768
Expression of a novel, sterol-insensitive form of sterol reg...
ACCEPT
Summary: A germ-cell SREBP2 isoform (SREBP2gc) is a soluble, constitutively active transcription factor.
Reason: Rat/mouse spermatogenic SREBP2gc activates SRE-containing promoters without sterol feedback. The activity is the canonical pol II activator function.
Supporting Evidence:
PMID:12446768
This protein, SREBP2gc, is expressed in a stage-dependent fashion as a soluble, constitutively active transcription factor that is not subject to feedback control by sterols.
GO:0046983 protein dimerization activity
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro bHLH/bHLH-Zip domain mapping to protein dimerization activity.
Reason: The bHLH-Zip domain mediates homodimerization of the nuclear form, which is needed for DNA binding and importin-beta-dependent import (Reactome R-HSA-2065549). True, but supporting rather than core.
Supporting Evidence:
Reactome:R-HSA-2065549
The N-terminal domains of SREBPs (SREBP1A/1C/2, SREBFs) dimerize via interaction of their helix-loop-helix leucine zipper domains
GO:0070888 E-box binding
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: Nuclear SREBP2 binds consensus and ABCA1 E-box sequences.
Reason: E-box binding is a genuine dual specificity of the SREBP bHLH domain (a tyrosine in the basic region allows SRE-1 binding). For SREBP-2, however, E-box binding does not lead to activation (PMID:12177166), and the ABCA1 E-box case is repression. The core specificity is SRE-1.
Supporting Evidence:
PMID:15358760
sterol depletion and SREBP2(N) overexpression induced the binding of SREBP2(N) to both consensus and ABCA1-specific E-box
PMID:12177166
SREBP-2 was inactive in spite of its ability to bind to the E-box
file:human/SREBF2/SREBF2-uniprot.txt
Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (PubMed:12177166, PubMed:7903453).
GO:0071404 cellular response to low-density lipoprotein particle stimulus
IEP
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: SREBP2 activity responds to cellular sterol status.
Reason: SREBP-2 processing is suppressed by LDL-derived cholesterol and activated by sterol depletion, so a response to LDL is a genuine feature of its regulation. The IEP evidence is expression-based and the term is peripheral.
Supporting Evidence:
PMID:15358760
sterol depletion activated SREBP2 and increased its target, low density lipoprotein receptor mRNA
GO:0071499 cellular response to laminar fluid shear stress
NAS
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
MARK AS OVER ANNOTATED
Summary: Cellular response to laminar fluid shear stress.
Reason: The cached abstract reports that oscillatory flow, not laminar flow, activated SREBP2 in endothelial cells. A response to laminar shear is not supported by the available text, and the NAS evidence is weak.
Supporting Evidence:
PMID:15358760
oscillatory flow caused the activation of SREBP2 and therefore attenuated ABCA1 promoter activity in ECs
GO:0090370 negative regulation of cholesterol efflux
IDA
PMID:15358760
Sterol-responsive element-binding protein (SREBP) 2 down-reg...
KEEP AS NON CORE
Summary: Nuclear SREBP2 decreases apoA-I-mediated cholesterol efflux by repressing ABCA1.
Reason: Supported by the abstract; acts through ABCA1 repression. Non-core.
Supporting Evidence:
PMID:15358760
Functionally adenovirus-mediated SREBP2(N) expression increased cholesterol accumulation and decreased apoA-I-mediated cholesterol efflux.
PMID:15358760
Overexpression of the N terminus of SREBP2 (SREBP2(N)), an active form of SREBP2, also inhibited the ABCA1 promoter activity.
GO:1900222 negative regulation of amyloid-beta clearance
IMP
PMID:19098903
SRF and myocardin regulate LRP-mediated amyloid-beta clearan...
MARK AS OVER ANNOTATED
Summary: In this model, SREBP2-mediated LRP1 repression in cerebral VSMCs reduces amyloid-beta clearance.
Reason: This is a distal consequence of LRP1 repression. SREBF2 does no step of amyloid-beta clearance; it lowers expression of the receptor that does. The knockdown shows necessity in this cell-type context, not participation, so the process term overstates SREBF2's role.
Supporting Evidence:
PMID:19098903
silencing SREBP2 with siSREBP2 resulted in loss of LRP suppression after Ad.MYOCD gene transfer
GO:1901524 regulation of mitophagy
HMP
PMID:24912190
Genome-wide RNAi screen identifies the Parkinson disease GWA...
MARK AS OVER ANNOTATED
Summary: Genome-wide RNAi screen for regulators of Parkin translocation and mitophagy.
Reason: The paper's validated hit is SREBF1, and the cached text does not discuss SREBF2. A screen hit of this kind most likely reflects a lipid-supply requirement, not a role in mitophagy regulation.
GO:1902895 positive regulation of miRNA transcription
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Positive regulation of miRNA transcription, transferred from mouse Srebf2.
Reason: SREBP-2 can activate miRNA genes with SRE-containing promoters (from the mouse annotation). The term is plausible but peripheral to cholesterol-gene activation.
GO:1903749 obsolete positive regulation of protein localization to mitochondrion
HMP
PMID:24912190
Genome-wide RNAi screen identifies the Parkinson disease GWA...
MARK AS OVER ANNOTATED
Summary: Screen-based term (now obsolete) for positive regulation of protein localization to mitochondrion.
Reason: Same screen as the mitophagy row. SREBF2 is not discussed in the cached text, and the term is obsolete in current GO.
GO:1990837 sequence-specific double-stranded DNA binding
IDA
PMID:28473536
Impact of cytosine methylation on DNA binding specificities ...
MODIFY
Summary: HT-SELEX (methyl-SELEX) profiling of human TF DNA-binding specificity included SREBF2.
Reason: True, but generic sequence-specific dsDNA binding. SREBF2's established binding sites are SRE-1 and E-box elements in pol II promoters, so GO:0000978 (already carried by IBA and IDA) is the better term. The cached text of this large screen does not discuss SREBF2 individually.
Supporting Evidence:
file:human/SREBF2/SREBF2-uniprot.txt
Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (PubMed:12177166, PubMed:7903453).

Core Functions

Nuclear SREBF2 (the released bHLH-Zip N-terminal domain) is a sequence-specific RNA polymerase II transcription activator. It binds sterol regulatory elements and activates the genes for cholesterol biosynthesis and LDL receptor-mediated uptake, increasing cellular cholesterol synthesis.

Supporting Evidence:
  • PMID:7903453
    In vitro SREBP-2 bound SRE-1 with the same specificity as SREBP-1a. In vivo it mimicked SREBP-1a in activating transcription of reporter genes containing SRE-1.
  • PMID:12177166
    cholesterogenic genes containing classic SREs in their promoters are strongly and efficiently activated by both SREBP-1a and SREBP-2, but not by SREBP-1c
  • PMID:11994399
    SREBP-2 preferentially activates the LDL receptor gene and various genes required for cholesterol synthesis
  • PMID:8674110
    The liberated NH2-segment enters the nucleus and activates genes controlling cholesterol synthesis and uptake.

The membrane-bound SREBF2 precursor is the cargo and sensor output of the sterol-regulated ER-to-Golgi checkpoint. Its C-terminal domain binds SCAP, forming the SREBP-SCAP complex, which INSIG retains in the ER membrane when sterols are high. When sterols are low, the complex moves to the Golgi membrane for S1P/S2P cleavage.

Supporting Evidence:
  • PMID:9242699
    Co-immunoprecipitation experiments show that SCAP and SREBP-2 form a complex that can be precipitated with antibodies to either component.
  • PMID:12202038
    In sterol-depleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis.
  • PMID:12242332
    The coimmunoprecipitation experiment of Fig. 3 B confirms that insig-2 binds to the SCAP/SREBP-2 complex only in the presence of sterols.
  • PMID:8674110
    The first, regulated by sterols, occurs in the lumenal loop. The second, not regulated by sterols, occurs within the first transmembrane domain.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: How is SREBP-2 processing kept sterol-sensitive while SREBP-1a processing escapes sterol control in fatty-acid-depleted cells, if both are carried by the same SCAP?

Q: Does nuclear SREBP-2 repress genes such as ABCA1 and LRP1 directly through E-box binding in vivo, or are these effects mainly secondary to changes in sterol status and LXR activity?

Q: Should the substrate role of SREBF2 in S1P/S2P-mediated regulated intramembrane proteolysis be captured as has_input on the protease activities in GO-CAM, rather than as a process annotation on SREBF2?

Suggested Experiments

Experiment: In endothelial and vascular smooth muscle cells with endogenous SREBF2 replaced by DNA-binding-dead or SRE-only (bHLH tyrosine-to-arginine) variants, combine CUT&RUN for nuclear SREBP-2 with promoter E-box editing and nascent-transcript measurement, holding cellular sterol constant with LXR agonist/antagonist controls.

Hypothesis: SREBP-2 repression of ABCA1 and LRP1 is a direct, E-box-dependent activity of the nuclear form.

Type: Genome editing with chromatin occupancy and nascent transcription assays

πŸ“š Additional Documentation

Notes

(SREBF2-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)